ALPS Advisors’s Tectonic Therapeutic TECX Stock Holding History

ALPS Advisors’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$603K	Buy	25,886 +6,739	+35%	+$211K	﹤0.01%	837
2026 Q2	$658K	Buy	19,147 +3,861	+25%	+$113K	﹤0.01%	833
2026 Q1	$472K	Sell	15,286 -83	-0.5%	-$2.04K	﹤0.01%	907
2025 Q4	$321K	Buy	+15,369	New	+$286K	﹤0.01%	933
2021 Q2	–	Sell	-6,250	Closed	-$952K	–	922
2021 Q1	$952K	Buy	6,250 +761	+14%	+$124K	0.01%	401
2020 Q4	$918K	Buy	5,489 +1,617	+42%	+$287K	0.01%	396
2020 Q3	$605K	Sell	3,872 -224	-5%	-$45.1K	0.01%	403
2020 Q2	$858K	Buy	+4,096	New	+$844K	0.01%	355

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ALPS Advisors's TECX Position: Q3 2026 in Review

ALPS Advisors increased its Tectonic Therapeutic (TECX) stake by 35% in Q3 2026, buying an estimated $211K and bringing the position to 25,886 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

ALPS Advisors first reported a position in TECX in Q2 2020 and has held it in 8 quarters since. The position peaked at $952K in Q1 2021. 55 funds tracked by Wall St. Rank hold TECX as of Q3 2026.

ALPS Advisors held 25,886 shares of Tectonic Therapeutic worth $603K as of Q3 2026.
ALPS Advisors bought 6,739 Tectonic Therapeutic shares in Q3 2026, an estimated $211K.
Tectonic Therapeutic made up ﹤0.01% of ALPS Advisors's portfolio in Q3 2026, its #837 holding.
ALPS Advisors first reported a position in Tectonic Therapeutic in Q2 2020 and has held it in 8 quarters since.
ALPS Advisors's Tectonic Therapeutic position peaked at $952K in Q1 2021.
55 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2026.

Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.